Free Trial

Grainger (GRI) Competitors

Grainger logo
GBX 197.80 -8.20 (-3.98%)
As of 04/4/2025 01:02 PM Eastern

GRI vs. SOPH, ITH, HCM, INDV, SLS, ERGO, BMY, SLN, AMYT, and OGN

Should you be buying Grainger stock or one of its competitors? The main competitors of Grainger include Sophos Group plc (SOPH.L) (SOPH), Ithaca Energy (ITH), HUTCHMED (HCM), Indivior (INDV), Standard Life UK Smaller Companies Trust (SLS), Ergomed (ERGO), Bloomsbury Publishing (BMY), Silence Therapeutics (SLN), Amryt Pharma (AMYT), and Origin Enterprises (OGN). These companies are all part of the "pharmaceutical products" industry.

Grainger vs.

Grainger (LON:GRI) and Sophos Group plc (SOPH.L) (LON:SOPH) are both real estate companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, earnings, community ranking, dividends, analyst recommendations, institutional ownership and valuation.

Sophos Group plc (SOPH.L) has higher revenue and earnings than Grainger. Grainger is trading at a lower price-to-earnings ratio than Sophos Group plc (SOPH.L), indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Grainger£276.05M5.29-£1.11M-£0.15-1,318.67
Sophos Group plc (SOPH.L)£726.90M0.00N/A£1.70N/A

Sophos Group plc (SOPH.L) has a net margin of 0.00% compared to Grainger's net margin of -0.40%. Sophos Group plc (SOPH.L)'s return on equity of 0.00% beat Grainger's return on equity.

Company Net Margins Return on Equity Return on Assets
Grainger-0.40% -0.06% 2.14%
Sophos Group plc (SOPH.L) N/A N/A N/A

Grainger presently has a consensus price target of GBX 317.50, suggesting a potential upside of 60.52%. Given Grainger's stronger consensus rating and higher possible upside, equities analysts plainly believe Grainger is more favorable than Sophos Group plc (SOPH.L).

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Grainger
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Sophos Group plc (SOPH.L)
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Grainger pays an annual dividend of GBX 7 per share and has a dividend yield of 3.5%. Sophos Group plc (SOPH.L) pays an annual dividend of GBX 0.04 per share. Grainger pays out -4,666.7% of its earnings in the form of a dividend. Sophos Group plc (SOPH.L) pays out 2.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Grainger is clearly the better dividend stock, given its higher yield and lower payout ratio.

Grainger received 246 more outperform votes than Sophos Group plc (SOPH.L) when rated by MarketBeat users. However, 80.19% of users gave Sophos Group plc (SOPH.L) an outperform vote while only 78.09% of users gave Grainger an outperform vote.

CompanyUnderperformOutperform
GraingerOutperform Votes
663
78.09%
Underperform Votes
186
21.91%
Sophos Group plc (SOPH.L)Outperform Votes
417
80.19%
Underperform Votes
103
19.81%

In the previous week, Grainger had 5 more articles in the media than Sophos Group plc (SOPH.L). MarketBeat recorded 5 mentions for Grainger and 0 mentions for Sophos Group plc (SOPH.L). Grainger's average media sentiment score of 0.89 beat Sophos Group plc (SOPH.L)'s score of 0.00 indicating that Grainger is being referred to more favorably in the media.

Company Overall Sentiment
Grainger Positive
Sophos Group plc (SOPH.L) Neutral

85.8% of Grainger shares are held by institutional investors. 1.9% of Grainger shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Grainger beats Sophos Group plc (SOPH.L) on 11 of the 17 factors compared between the two stocks.

Remove Ads
Get Grainger News Delivered to You Automatically

Sign up to receive the latest news and ratings for GRI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GRI vs. The Competition

MetricGraingerReal Estate Services IndustryReal Estate SectorLON Exchange
Market Cap£1.46B£1.48B£1.49B£2.43B
Dividend Yield3.53%5.01%6.67%4.94%
P/E Ratio-1,318.6719.609.08127.39
Price / Sales5.29172.57358.92261,764.23
Price / Cash19.2219.6467.9628.19
Price / Book0.771.911.164.37
Net Income-£1.11M-£421.01M-£116.63M£5.83B
7 Day Performance-3.98%-1.90%-2.12%2.02%
1 Month Performance-2.08%-5.30%-2.90%0.16%
1 Year Performance-23.04%-3.05%-0.17%96.02%

Grainger Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GRI
Grainger
3.2713 of 5 stars
GBX 197.80
-4.0%
GBX 317.50
+60.5%
-23.8%£1.46B£276.05M-1,318.67372Dividend Increase
Insider Trade
News Coverage
High Trading Volume
SOPH
Sophos Group plc (SOPH.L)
N/AN/AN/AN/A£2.99B£726.90M341.41520
ITH
Ithaca Energy
N/AGBX 142.40
+3.9%
N/A+7.6%£2.97B£3.55B16.26220News Coverage
Gap Down
HCM
HUTCHMED
N/AGBX 228
-2.1%
N/A-18.4%£2.48B£771.01M-58.191,760
INDV
Indivior
2.0032 of 5 stars
GBX 764.50
-1.1%
GBX 1,650
+115.8%
-58.4%£1.19B£1.40B-633.881,000News Coverage
Gap Up
SLS
Standard Life UK Smaller Companies Trust
N/AN/AN/AN/A£715.41M£222.48M3.3710
ERGO
Ergomed
N/AN/AN/AN/A£701.00M£152.09M4,641.386
BMY
Bloomsbury Publishing
2.1922 of 5 stars
GBX 606.32
+1.4%
GBX 825
+36.1%
+7.3%£489.26M£382.40M12.9734,300Positive News
SLN
Silence Therapeutics
N/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading Volume
AMYT
Amryt Pharma
N/AN/AN/AN/A£457.11M£210.24M-4.33290Gap Down
OGN
Origin Enterprises
N/AGBX 2.96
flat
N/A+0.0%£312.54M£183.08B8.5610,000Dividend Increase
Remove Ads

Related Companies and Tools


This page (LON:GRI) was last updated on 4/5/2025 by MarketBeat.com Staff
From Our Partners